CANF · AMEX · Biotechnology

Can-Fite BioPharma (ADR) (CANF)

Develops oral A3AR-targeted drug candidates for psoriasis, liver cancer and metabolic liver disease.

$2.40
Pre-market+0.03 (+1.27%)
At close$2.37(−27.96%)

Breakdown13F · 13D/G · Form 4

Institutions14 holders · as of Dec 31, 202545.56%29.8K ADS
Otherremainder54.44%35.6K ADS

65.5K ADS (1 ADS = 2 ordinary shares) as of Sep 3, 2026 · institutions as of Dec 31, 2025 · holders as of their latest filing

Two share counts disagree (65.5K in the company's Sep 3, 2026 report, 1.31M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Rhumbline AdvisersInstitution
21.53%281,881 ADS13Fas of Dec 31, 2025
Jane Street Group, LLCInstitution
15.66%205,004 ADS13Fas of Dec 31, 2025
Advisor Group Holdings, Inc.Institution
2.75%36,000 ADS13Fas of Dec 31, 2025
UBS Group AGInstitution
1.60%20,942 ADS13Fas of Dec 31, 2025
XTX Topco LtdInstitution
1.43%18,686 ADS13Fas of Dec 31, 2025
Bogart Wealth, LLCInstitution
1.15%15,045 ADS13Fas of Dec 31, 2025
Two Sigma Securities, LLCInstitution
0.92%12,088 ADS13Fas of Dec 31, 2025
Fifth Third BancorpInstitution
0.23%3,000 ADS13Fas of Dec 31, 2025
Wells Fargo & Company/MNInstitution
0.19%2,500 ADS13Fas of Dec 31, 2025
Costello Asset Management, IncInstitution
0.08%1,000 ADS13Fas of Dec 31, 2025
Activest Wealth ManagementInstitution
0.02%200 ADS13Fas of Dec 31, 2025
Eversource Wealth Advisors, LLCInstitution
0.01%68 ADS13Fas of Dec 31, 2025
Morgan StanleyInstitution
0.00%33 ADS13Fas of Dec 31, 2025
TD Waterhouse Canada Inc.Institution
0.00%20 ADS13Fas of Dec 31, 2025
13g/aInsider
0.60% of class, as filed13G/Afiled Feb 14, 2020
Armistice Capital, LLCStrategic
9.99% of class, as filed13D/Gfiled Feb 14, 2024
CVI Investments, Inc.Strategic
3.70% of class, as filed13G/Afiled Feb 14, 2022
Capital Point Ltd.Strategic
10.38% of class, as filed13D/Gfiled May 30, 2019
Hudson Bay Capital Management LPInstitution
7.53% of class, as filed13Gfiled Jan 31, 2020
Intracoastal Capital LLCStrategic
4.99% of class, as filed13G/Afiled Feb 11, 2022
Meitav Dash Investments Ltd.Strategic
3.49% of class, as filed13D/Gfiled May 13, 2019
Taylor Asset  Management Inc.Institution
4.87% of class, as filed13G/Afiled Feb 14, 2018

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more

Institutions13F, as of Dec 31, 2025

14 holders · 596.5K shares · 3 new positions · 6 increased · 2 reduced · 4 closed

HolderShares% outstandingChg q/qFiled
Rhumbline Advisers281.9K430.62%+223.9KFeb 13, 2026
Jane Street Group, LLC205.0K313.17%+205.0KnewFeb 12, 2026
Advisor Group Holdings, Inc.36.0K55.00%+36.0KFeb 17, 2026
UBS Group AG20.9K31.99%+19.6KJan 29, 2026
XTX Topco Ltd18.7K28.55%+18.7KnewFeb 17, 2026
Bogart Wealth, LLC15.0K22.98%0Jan 30, 2026
Two Sigma Securities, LLC12.1K18.47%+1.4KFeb 17, 2026
Fifth Third Bancorp3.0K4.58%0Feb 2, 2026

Ownership statements13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Insider tradesForm 4

Latest trades

Nothing filed in the last 12 months.

CongressHouse and Senate disclosures

Not reported.